Buy Ranbaxy on dips: Vibhav Kapoor

53658 Investors following Ranbaxy Labs. Share this News with them.

0

Like this story, share it with millions of investors on M3

Buy Ranbaxy on dips: Vibhav Kapoor

Buy Ranbaxy Laboratories on dips, says Vibhav Kapoor, IL&FS.

Post your opinion here

 

0

Tweet

Share on Tumblr

Excerpts from Bazaar on CNBC-TV18 Watch the full show » ALSO READ See previous views by Vibhav Kapoor See what other Experts & Brokerages are saying about Ranbaxy Labs See messages about Ranbaxy Labs Ranbaxy Labs BSE | NSE 17/02/12 Are Mutual Funds betting on Ranbaxy Labs?

Buy Ranbaxy Laboratories on dips, says Vibhav Kapoor , IL&FS.

Kapoor told CNBC-TV18, "Ranbaxy Laboratories seems to be getting out of its bad phase for the last two years or so. It had a terrible time. So things seem to be improving for them but the stock is not cheap. So if you are a medium-term investor, it is probably good to buy at dips, accumulate the stock, there could be further upside going forward over the next twelve-eighteen months."

He further added, " Suzlon Energy is a slightly different case, it has had so many disappointments, the company has not been able to meet its promises to investors. But now I think they are starting to reduce their debt. So that is one very important issue as to how much debt they can reduce, how much improvement they can do with their balance sheet and of course this news about getting a new order is also positive. So I think there could be a sense that the worst could be getting over for this company and if you are a long-term investor and if you believe in the management then I think it could be a good interesting stock to look at and accumulate gradually."